510(k) K242585
K242585 is an FDA 510(k) premarket notification submitted by SENTINEL CH. SpA for the device "Cystatin C". The FDA issued a decision of Substantially Equivalent on May 16, 2025. The device falls under product code NDY (Test, Cystatin C), a Class II device regulated under 21 CFR 862.1225. SENTINEL CH. SpA has 21 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 16, 2025
- Date Received
- Aug 30, 2024
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Test, Cystatin C
- Device Class
- Class II
- Regulation Number
- 862.1225
- Review Panel
- CH
- Submission Type
- 510(k)
Need the full FDA record for SENTINEL CH. SpA? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.